Verification evidence is still being completed.
PDF / print export
Bioglan
Malmo, Sweden
- Verified lead
- Simon Bjorklund
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- CEO
- 2026 technical specialization
- CDMO, Semi-Solid Manufacturing, Pharmaceutical Development, Clinical Trial Material, and MedTech Formulations
- Review cycle
- May 2026
- Full address
- Borrgatan 31, SE-211 24 Malmo, Sweden
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Bioglan location page confirming the Malmo production facility and headquarters address.
- Editorial note
- Bioglan is published because official company materials confirm current leadership, Malmo operating address, and a real Swedish CDMO and production footprint.
CDMO, Semi-Solid Manufacturing, Pharmaceutical Development, Clinical Trial Material, and MedTech Formulations
Official leadership disclosure, Official Malmo facility disclosure, EU GMP and ISO 13485 disclosure
Bioglan is published because official company materials confirm current leadership, Malmo operating address, and a real Swedish CDMO and production footprint.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Bioglan runs contract development and manufacturing, semi-solid and liquid formulation, and clinical trial material production in Malmo, Sweden.
- Lead
- Simon Bjorklund (verified ↗)
- Address
- Borrgatan 31, SE-211 24 Malmo, Sweden (source ↗)
- Compliance
- EU GMP and ISO 13485 disclosure
- Last reviewed
- 22 Mar 2026 (2mo ago)
- Scale
- Commercial and clinical manufacturing platform
- Capabilities
- Contract Development and Manufacturing · Semi-Solid and Liquid Formulation · Clinical Trial Material Production
- Founded
- 1984
- Headcount
- 51-200
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Simon Bjorklund
CEO
Full addressBorrgatan 31, SE-211 24 Malmo, Sweden
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official Bioglan location page listing the Malmo production facility address.
Open sourceCommercial and clinical manufacturing platform
Malmo, Sweden. CDMO, Semi-Solid Manufacturing, Pharmaceutical Development, Clinical Trial Material, and MedTech Formulations. Review completed on 22 Mar 2026.
Swedish pharmaceutical manufacturing and medical-device oversight
Official leadership disclosure, Official Malmo facility disclosure, EU GMP and ISO 13485 disclosure
CDMO, Semi-Solid Manufacturing, Pharmaceutical Development, Clinical Trial Material, and MedTech Formulations
Bioglan is published because official company materials confirm current leadership, Malmo operating address, and a real Swedish CDMO and production footprint.
Editorial note
Bioglan is published because official company materials confirm current leadership, Malmo operating address, and a real Swedish CDMO and production footprint.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Contract Development and Manufacturing
Semi-Solid and Liquid Formulation
Clinical Trial Material Production
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Semi-solid manufacturing lines
Liquid product manufacturing systems
Clinical trial material production infrastructure
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
Verification history
Verification history
22 Mar 2026: Executive identity confirmed via official management disclosure.
22 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Bioglan located?
- Bioglan operates from Borrgatan 31, SE-211 24 Malmo, Sweden, Malmo, Sweden.
- Who runs Bioglan?
- Bioglan is led by Simon Bjorklund, CEO. Verified 22 Mar 2026.
- What certifications does Bioglan hold?
- Bioglan is documented under EU GMP and ISO 13485 disclosure.
- What does Bioglan do?
- Bioglan runs contract development and manufacturing, semi-solid and liquid formulation, and clinical trial material production in Malmo, Sweden. Core capabilities: Contract Development and Manufacturing, Semi-Solid and Liquid Formulation, Clinical Trial Material Production.
Editorial context
Related technical briefs
Briefs that name Malmo as a covered market or city.